Literature DB >> 24037576

Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.

N Harimoto1, K Shirabe, Y-I Yamashita, T Ikegami, T Yoshizumi, Y Soejima, T Ikeda, Y Maehara, A Nishie, T Yamanaka.   

Abstract

BACKGROUND: Sarcopenia was identified recently as a poor prognostic factor in patients with cancer. The present study investigated the effect of sarcopenia on short- and long-term outcomes following partial hepatectomy for hepatocellular carcinoma (HCC), and aimed to identify prognostic factors.
METHODS: Data were collected retrospectively for all consecutive patients who underwent hepatectomy for HCC with curative intent between January 2004 and December 2009. Patients were assigned to one of two groups according to the presence or absence of sarcopenia, assessed by computed tomographic measurement of muscle mass at the level of the third lumbar vertebra. Clinicopathological, surgical outcome and long-term survival data were analysed.
RESULTS: Sarcopenia was present in 75 (40·3 per cent) of 186 patients, and was significantly correlated with female sex, lower body mass index and liver dysfunction, as indicated by abnormal serum albumin levels and indocyanine green retention test at 15 min values. In patients with, and without sarcopenia, the 5-year overall survival rate was 71 and 83·7 per cent respectively, and the 5-year recurrence-free survival rate was 13 and 33·2 per cent respectively. Multivariable analysis revealed that reduced skeletal muscle mass was predictive of an unfavourable prognosis.
CONCLUSION: Sarcopenia was predictive of worse overall survival even when adjusted for other known predictors in patients with HCC after partial hepatectomy.
© 2013 British Journal of Surgery Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 24037576     DOI: 10.1002/bjs.9258

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  137 in total

1.  Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma.

Authors:  Robert J S Coelen; Jimme K Wiggers; Chung Y Nio; Marc G Besselink; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

Review 2.  The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature.

Authors:  Savita Joglekar; Peter N Nau; James J Mezhir
Journal:  J Surg Oncol       Date:  2015-08-27       Impact factor: 3.454

3.  Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma.

Authors:  Tomoyuki Abe; Hirotaka Tashiro; Tsuyoshi Kobayashi; Minoru Hattori; Shintaro Kuroda; Hideki Ohdan
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

4.  Reply to the Comments.

Authors:  Yukihiro Yokoyama; Hidehiko Otsuji; Masato Nagino
Journal:  World J Surg       Date:  2015-09       Impact factor: 3.352

5.  Postoperative Skeletal Muscle Loss Predicts Poor Prognosis of Adenocarcinoma of Upper Stomach and Esophagogastric Junction.

Authors:  Kensuke Kudou; Hiroshi Saeki; Yuichiro Nakashima; Koichi Kimura; Koji Ando; Eiji Oki; Tetsuo Ikeda; Yoshihiko Maehara
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

Review 6.  The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.

Authors:  Hánah N Rier; Agnes Jager; Stefan Sleijfer; Andrea B Maier; Mark-David Levin
Journal:  Oncologist       Date:  2016-07-13

7.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

8.  Sarcopenia is a predictive factor for prolonged intensive care unit stays in high-energy blunt trauma patients.

Authors:  Tomohiko Akahoshi; Mitsuhiro Yasuda; Kenta Momii; Kensuke Kubota; Yuji Shono; Noriyuki Kaku; Kentaro Tokuda; Takashi Nagata; Tomoharu Yoshizumi; Ken Shirabe; Makoto Hashizume; Yoshihiko Maehara
Journal:  Acute Med Surg       Date:  2016-05-02

9.  Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.

Authors:  Soichi Iritani; Kenji Imai; Koji Takai; Tatsunori Hanai; Takayasu Ideta; Tsuneyuki Miyazaki; Atsushi Suetsugu; Makoto Shiraki; Masahito Shimizu; Hisataka Moriwaki
Journal:  J Gastroenterol       Date:  2014-05-10       Impact factor: 7.527

Review 10.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.